Telemedicine in lung cancer during COVID‑19 outbreak: A scoping review
نویسندگان
1 Department of Health Information Technology, School of Allied Medical Sciences, Lorestan University of Medical Sciences, Khorramabad, Iran
2 Department of Health Information Technology, School of Allied Medical Sciences, Lorestan University of Medical Sciences, Khorramabad, Iran
3 Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran Education Development Center, Iran University of Medical Sciences, Tehran, Iran ƗFirst authors: Ali Gravand and Nasim Aslani contributed equally to this study
4 Bone and Joint Reconstruction Research Center, Department of Orthopedics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran
doi
چکیده
Abstract:The coronavirus disease 2019 (COVID‑19) pandemic has negatively affected the medical services,particularly cancer diagnosis and treatment, for vulnerable cancer patients. Although lung cancerhas a high mortality rate, monitoring and following up of these patients can help to improve diseasemanagement during the pandemic. Telemedicine has proven to be an effective method of providinghealth care to these patients. As a result, the purpose of this study was to identify telemedicineapplications in the management of lung cancer patients during the COVID‑19 pandemic. In this scopingreview, studies published in online scientific databases such as Web of Science, Scopus, and PubMedbetween January 1, 2020 and September 1, 2021 were systematically searched and screened. Thestudies were chosen using predetermined inclusion and exclusion criteria. The bibliometric informationand technological aspects of included studies were collected using a data extraction form and thedata was analyzed using the content analysis approach. A total of 68 articles were found, from whichfour articles were finally selected based on specific inclusion/exclusion criteria. Real‑time consultationwas one of the most common applications of telemedicine to deliver health‑care services to cancerpatients. Health‑care providers used applications such as Zoom, Facetime, WeChat, and e‑mail,as well as devices including PCs, phones, and smartphones to provide real‑time consultation topatients via videoconferencing, phone calls, and messaging, as well as store and forward consultationvia e‑mail. Telemedicine in the COVID‑19 pandemic provides health‑care services to lung cancerpatients at their homes by enabling physicians and patients to communicate in real time. Severaltelemedicine services are still unavailable for patients with lung cancer. As a result, health experts,politicians, and entrepreneurs must pay special attention to this issue.